Epigenetic disruption of cell signaling in nasopharyngeal carcinoma

Chinese Journal of Cancer

Volumn 30, Issue 4, 2011, Pages 231-239

  Li, Li Li ^a,b,c   Shu, Xing Sheng ^b   Wang, Zhao Hui ^a,b   Cao, Ya ^c   Tao, Qian ^a,b  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Central South University   (China)

Author keywords

Cell signaling; Epigenetic; Nasopharyngeal neoplasm

Indexed keywords

BETA CATENIN; CASPASE 8; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA METHYLTRANSFERASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; LATENT MEMBRANE PROTEIN 1; MATRIX METALLOPROTEINASE 19; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MISMATCH REPAIR PROTEIN; MUT L HOMOLOG 1 PROTEIN; PROTEIN CHFR; PROTEIN GADD45G; PROTEIN IGSF4; PROTEIN P53; PROTEIN TSLC1; RAS PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN; WNT PROTEIN;

APOPTOSIS; BRD7 GENE; CANCER RESEARCH; CARCINOGENESIS; CELL ACTIVITY; CELL ADHESION; CELL CYCLE REGULATION; CELL SIGNALLING; CPG ISLAND; DNA DAMAGE; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; EPSTEIN BARR VIRUS; GENE; GENE DISRUPTION; HUMAN; NASOPHARYNX CARCINOMA; NONHUMAN; PCDH10 GENE; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 79954550436     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10080     Document Type: Review

References (53)

1. Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments [J]. Expert Rev Mol Med, 2007,9(12):1-24.
2. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma [J]. Cancer Cell, 2004,5(5):423-428.
3. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma [J]. Semin Cancer Biol, 2002,12(6): 451-462.
4. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer [J]. Nat Rev Genet, 2002,3(6):415-428.
5. Jones PA, Baylin SB. The epigenomics of cancer [J]. Cell, 2007,128(4):683-692.
6. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? [J]. Nat Rev Cancer, 2006,6(2):107-116.
7. Downward J. Targeting RAS signalling pathways in cancer therapy [J]. Nat Rev Cancer, 2003,3(1):11-22.
8. Vigil D, Cherfils J, Rossman KL, et al. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? [J]. Nat Rev Cancer, 2010,10(12):842-857.
9. Jin H, Wang X, Ying J, et al. Epigenetic silencing of a Ca(2+)- regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers [J]. Proc Natl Acad Sci USA, 2007,104(30):12353-12358.
10. Wong TS, Tang KC, Kwong DL, et al. Differential gene methylation in undifferentiated nasopharyngeal carcinoma [J]. Int J Oncol, 2003,22(4):869-874.
11. Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma [J]. Cancer Res, 2001,61(10):3877-3881.
12. Chang HW, Chan A, Kwong DL, et al. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharyngeal carcinoma patient [J]. Int J Cancer, 2003,105(6):851-855.
13. Wong TS, Kwong DL, Sham JS, et al. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma [J]. Clin Cancer Res, 2004,10(7): 2401-2406.
14. Kwong J, Lo KW, To KF, et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma [J]. Clin Cancer Res, 2002,8(1):131-137.
15. Tong JH, Ng DC, Chau SL, et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma [J]. BMC Cancer, 2010,10:253.
16. Wong TS, Kwong DL, Sham JS, et al. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma [J]. Clin Cancer Res, 2003,9(8): 3042-3046.
17. Tcherkezian J, Lamarche-Vane N. Current knowledge of the large RhoGAP family of proteins [J]. Biol Cell, 2007,99(2):67-86.
18. Seng TJ, Low JS, Li H, et al. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation [J]. Oncogene, 2007,26(6):934-944.
19. Kunimi K, Amano T, Uchibayashi T. Point mutation of the p53 gene is an infrequent event in untreated prostate cancer [J]. Cancer Detect Prev, 1996,20(3):218-222.
20. Spruck CH 3rd, Tsai YC, Huang DP, et al. Absence of p53 gene mutations in primary nasopharyngeal carcinomas [J]. Cancer Res, 1992,52(17):4787-4790.
21. Li L, Zhou S, Chen X, et al. The activation of p53 mediated by Epstein-Barr virus latent membrane protein 1 in SV40 large T-antigen transformed cells [J]. FEBS Lett, 2008,582(5):755-762.
22. Li L, Guo L, Tao Y, et al. Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases [J]. Cancer Lett, 2007,255(2):219-231.
23. Li L, Tao Q, Jin H, et al. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma [J]. Clin Cancer Res, 2010,16(11):2949-2958.
24. Clevers H. Wnt/beta-catenin signaling in development and disease [J]. Cell, 2006,127(3):469-480.
25. Ying Y, Tao Q. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers [J]. Epigenetics, 2009,4 (5):307-312.
26. Chan SL, Cui Y, van Hasselt A, et al. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas [J]. Lab Invest, 2007,87(7):644-650.
27. Hartwell LH, Kastan MB. Cell cycle control and cancer [J]. Science, 1994,266(5192): 1821-1828.
28. Collins K, Jacks T, Pavletich NP. The cell cycle and cancer [J]. Proc Natl Acad Sci USA, 1997,94(7):2776-2778.
29. Huang DP, Lo KW, van Hasselt CA, et al. A region of homozygous deletion on chromosome 9p21 -22 in primary nasopharyngeal carcinoma [J]. Cancer Res, 1994,54(15):4003-4006.
30. Lo KW, Cheung ST, Leung SF, et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma [J]. Cancer Res, 1996,56(12):2721-2725.
31. Liu H, Zhang L, Niu Z, et al. Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells [J]. BMC Cancer, 2008,8:253.
32. Cheung AK, Lung HL, Ko JM, et al. Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma [J]. Proc Natl Acad Sci USA, 2009,106(34):14478-14483.
33. Hegi ME, Sciuscio D, Murât A, et al. Epigenetic deregulation of NA repair and its potential for therapy [J]. Clin Cancer Res, 2009,15(16):5026-5031.
34. Amanullah A, Azam N, Balliet A, et al. Cell signalling: Cell urvival and a Gadd45-factor deficiency [J]. Nature, 2003,424 (6950):741-742.
35. Ying J, Srivastava G, Hsieh WS, et al. The stress-responsivegene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors [J]. Clin Cancer Res, 2005,11 (18):6442-6449.
36. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers [J]. Nature, 1998,396(6712):643-649.
37. Cheung HW, Ching YP, Nicholls JM, et al. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation [J]. Mol Carcinog, 2005,43(4):237-245.
38. Loyo M, Brait M, Kim MS, et al. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma [J]. Int J Cancer, 2011,128(6):1393-1403.
39. Cheung AK, Lung HL, Hung SC, et al. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma [J]. Cancer Res, 2008,68(19):8137-8145.
40. Birchmeier W. Cell adhesion and signal transduction in cancer. Conference on cadherins, catenins and cancer [J]. EMBO Rep, 2005,6(5):413-417.
41. Okegawa T, Pong RC, Li Y, et al. The role of cell adhesion molecule in cancer progression and its application in cancer therapy [J]. Ada Biochim Pol, 2004,51 (2):445-457.
42. Lung HL, Cheng Y, Kumaran MK, et al. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma [J]. Int J Cancer, 2004,112(4): 628-635.
43. Ying J, Li H, Seng TJ, et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation [J]. Oncogene, 2006,25(7): 1070-1080.
44. George SJ, Dwivedi A. MMPs, cadherins, and cell proliferation [J]. Trends Cardiovasc Med, 2004,14(3):100-105.
45. Chan KC, Ko JM, Lung HL, et al. Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma [J]. Int J Cancer, 2010 Dec 16. [Epub ahead of print]
46. Cui Y, Ying Y, van Hasselt A, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation [J]. PLoS One, 2008,3(8): e2990.
47. Wang S, Xiao X, Zhou X, et al. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma [J]. BMC Cancer, 2010,10:617.
48. Li HP, Leu YW, Chang YS. Epigenetic changes in virus-associated human cancers [J]. Cell Res, 2005,15(4):262-271.
49. Niller HH, Wolf H, Minarovits J. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia [J]. Semin Cancer Biol, 2009,19(3):158-164.
50. Mohammad HP, Baylin SB. Linking cell signaling and the epigenetic machinery [J]. Nat Biotechnol, 2010,28(10):1033-1038.
51. Tsai CN, Tsai CL, Tse KP, et al. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases [J]. Proc Natl Acad Sci USA, 2002,99(15): 10084-10089.
52. Tsai CL, Li HP, Lu YJ, et al. Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH(2)-terminal kinase signaling [J]. Cancer Res, 2006,66(24):11668-11676.
53. Song LB, Li J, Liao WT, et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells [J]. J Clin Invest, 2009,119(12):3626-3636.